Alchemia is a biotechnology company. The Company is engaged in the research and development of human therapeutics based on its proprietary drug discovery, dry targeting and synthesis technologies. The Company has two promising late stage assets in generic foundaparinux and HA-Irinotecan. The Company carried out its operations primarily in Australia and the United States.Data provided by Mergent, Inc.
|Effective Date||Nov 03, 2004|
|Industry||Pharma. & Biotech.|